MicroStrategy
MicroStrategy (NASDAQ: MSTR) is dedicated to enhancing the Bitcoin network through financial strategies, advocacy, and technological advancements. The company develops, distributes, and promotes its software platform through licensing agreements, cloud-based subscriptions, and related services.

Positive Growth Prospects
Growth Challenges
Technical Observation (on the daily chart):
MicroStrategy (MSTR) is in a corrective phase after a strong uptrend, with the price falling below the 50-day MA ($333.88) and nearing the 200-day MA ($231.96), a key support level. The RSI at 34.77 suggests oversold conditions, indicating a potential bounce if support holds. A recovery above the 50-day MA could signal bullish momentum, while a breakdown below the 200-day MA may lead to further declines towards $200. The next move will depend on whether buyers step in at current levels.


MicroStrategy's Q3 2024 results highlight both the opportunities and challenges of its aggressive bitcoin-focused strategy. The company has successfully raised capital, expanded its bitcoin reserves, and lowered interest expenses, but its core software business continues to see declining revenues, while significant impairment losses have deepened net losses. The ambitious 21/21 Plan and strong BTC Yield emphasize a commitment to shareholder value, though dependence on bitcoin price movements adds volatility and financial risk. Achieving long-term stability will require balancing digital asset growth with improvements in operational performance.
As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Watch’ rating has been given to MicroStrategy (NASDAQ: MSTR) at the closing market price of USD 255.43 as of February 28,2025.
Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.
Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.
Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is February 28,2025. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.